Leilani Morales

503 total citations
10 papers, 388 citations indexed

About

Leilani Morales is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leilani Morales has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leilani Morales's work include Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Leilani Morales is often cited by papers focused on Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Leilani Morales collaborates with scholars based in Belgium, United Kingdom and Switzerland. Leilani Morales's co-authors include Robert Paridaens, Patrick Neven, Marie-Rose Christiaens, D. Timmerman, Ignace Vergote, Erik Van Limbergen, Steven Pans, René Westhovens, Luc De Smet and An Carbonez and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

Leilani Morales

10 papers receiving 373 citations

Peers

Leilani Morales
Claudia Stahlberg Denmark
Merja B. Marttunen Finland
Alban Fabre France
Messan G. Amewou-Atisso United States
Mattias Hammarström Sweden
D.S. Allen United Kingdom
Robert F. Berris United States
Penny Powers United States
Ketil Bjarnason Denmark
Usha Sriram India
Claudia Stahlberg Denmark
Leilani Morales
Citations per year, relative to Leilani Morales Leilani Morales (= 1×) peers Claudia Stahlberg

Countries citing papers authored by Leilani Morales

Since Specialization
Citations

This map shows the geographic impact of Leilani Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilani Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilani Morales more than expected).

Fields of papers citing papers by Leilani Morales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leilani Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilani Morales. The network helps show where Leilani Morales may publish in the future.

Co-authorship network of co-authors of Leilani Morales

This figure shows the co-authorship network connecting the top 25 collaborators of Leilani Morales. A scholar is included among the top collaborators of Leilani Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilani Morales. Leilani Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Redondo, Andrés, Nicoletta Colombo, Lydia Dreosti, et al.. (2018). Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervical cancer (CC).. Journal of Clinical Oncology. 36(15_suppl). 5528–5528. 5 indexed citations
3.
Morales, Leilani, Steven Pans, Ben Van Calster, et al.. (2008). Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome. Journal of Clinical Oncology. 26(19). 3147–3152. 115 indexed citations
4.
Morales, Leilani, Patrick Neven, D. Timmerman, et al.. (2008). Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant. Breast Cancer Research and Treatment. 117(1). 77–81. 8 indexed citations
5.
Morales, Leilani, Steven Pans, Robert Paridaens, et al.. (2006). Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Research and Treatment. 104(1). 87–91. 95 indexed citations
6.
7.
Morales, Leilani, Patrick Neven, & Robert Paridaens. (2005). Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting. Current Opinion in Oncology. 17(6). 559–565. 26 indexed citations
8.
Morales, Leilani, Patrick Neven, D. Timmerman, et al.. (2004). Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs. 15(8). 753–760. 118 indexed citations
9.
Morales, Leilani, Patrick Neven, D. Timmerman, et al.. (2003). Prospective study on the effect of endocrine treatments on menopausal symptoms in breast cancer patients. Breast Cancer Research and Treatment. 82. 106–106. 1 indexed citations
10.
Morales, Leilani, D. Timmerman, Patrick Neven, et al.. (2003). Prospective study of uterine sonographic changes after 3 months endocrine treatment in postmenopausal breast cancer patients: tamoxifen is estrogenic while aromatase inhibitors induce atrophy and can reverse the effect of tamoxifen. Breast Cancer Research and Treatment. 82(1). 105–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Stahlberg Breakdown of academic impact, for papers by Merja B. Marttunen Breakdown of academic impact, for papers by Alban Fabre Breakdown of academic impact, for papers by Messan G. Amewou-Atisso Breakdown of academic impact, for papers by Mattias Hammarström Breakdown of academic impact, for papers by D.S. Allen Breakdown of academic impact, for papers by Robert F. Berris Breakdown of academic impact, for papers by Penny Powers Breakdown of academic impact, for papers by Ketil Bjarnason Breakdown of academic impact, for papers by Usha Sriram
Rankless by CCL
2026